Media

6117d506-0da7-463e-9973-527889dc2b31_tcm990-407483

Pfizer-BioNTech On December 11, 2020, this became the first COVID-19 vaccine to receive an FDA EUA, after the company reported positive clinical trial data, which included news that the vaccine was up to 95% more effective than a placebo at preventing symptomatic disease. But the Pfizer-BioNTech vaccine has had strict requirements involving how the vaccine is stored.

Serology (antibody) tests for the SARS-CoV-2 virus have the potential to inform good public health decision making during the pandemic. This report describes potential uses of the tests, areas of uncertainty where additional research is needed, and examples from other countries now beginning to make use of these tests.

oh-image-CHS
1800x1200_covid19_myths_you_shouldnt_believe_slideshow

April 16, 2021 -- People who’ve received both doses of the Pfizer-BioNTech or Moderna coronavirus vaccines will probably need a booster shot this year, top executives for those two ...

The development of a vaccine to protect against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an urgent biomedical need. Yu et al. designed a series of prototype DNA vaccines against the SARS-CoV-2 spike protein, which is used by the virus to bind and invade human cells. Analysis of the vaccine candidates in rhesus macaques showed that animals developed protective humoral and ...

F1.large
vaccicne

People who are fully vaccinated against Covid-19 no longer have to wear masks inside or outside, nor do they have to stay 6 feet away from others, according to new guidance released Thursday by the US Centers for Disease Control and Prevention.